Orthofix Medical Inc. (OFIX) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — OFIX

Balance Sheet

(in millions USD)

Metric	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	103.81	120.28	62.86	65.61	57.95	30.05	26.37	26.96	33.66	37.61	49.97	51.66	59.54	71.92	82.71	79.97	94.57
Accounts Receivable	135.82	137.78	130.81	129.56	131.87	124.85	125.36	125.62	114.12	112.32	113.31	75.63	77.07	72.47	68.97	73.45	69.68
Inventory	184.48	177.82	174.04	172.99	174.48	205.81	210.04	219.08	221.75	222.47	221.93	100.28	97.17	88.83	84.68	81.55	84.18
Total Current Assets	446.13	461.52	394.17	395.83	390.31	386.21	386.07	398.98	393.70	399.35	410.04	246.90	255.19	255.10	260.21	258.45	263.35
Property, Plant & Equipment	130.76	125.33	130.02	129.20	130.69	146.69	154.11	158.13	152.69	140.58	136.82	57.82	58.68	58.51	58.78	62.27	62.47
Goodwill	194.93	194.93	194.93	194.93	194.93	194.93	194.93	194.93	194.77	191.73	202.71	71.32	71.32	71.32	83.36	83.65	83.51
Intangible Assets	65.97	69.34	75.64	78.87	81.21	104.55	108.31	112.76	121.02	126.00	122.13	47.51	50.63	50.17	54.79	55.89	57.63
Total Non-current Assets*	426.89	425.08	438.44	441.33	432.83	481.66	495.93	507.07	511.96	501.94	507.10	202.77	206.46	206.89	240.18	243.56	250.52
Total Assets	873.02	886.60	832.61	837.16	823.14	867.87	882.00	906.05	905.65	901.29	917.14	449.66	461.66	461.99	500.40	502.01	513.87
Accounts Payable	63.53	54.69	50.46	45.10	45.18	47.06	50.36	57.15	53.26	51.35	45.88	28.00	32.32	27.45	19.44	20.10	21.06
Total Current Liabilities	157.01	161.03	159.85	148.38	144.12	161.90	155.97	150.62	152.53	141.80	137.57	77.65	81.10	88.21	80.00	81.65	99.06
Long-term Debt	221.59	221.34	157.22	157.05	156.89	118.47	118.00	118.20	70.00	51.00	45.00	--	--	--	--	--	--
Total Non-current Liabilities*	286.83	290.38	230.28	230.43	220.73	180.05	180.03	185.11	137.64	119.50	115.41	38.47	38.61	38.21	55.56	58.08	60.00
Total Liabilities	443.84	451.42	390.12	378.81	364.85	341.95	335.99	335.74	290.17	261.30	252.98	116.12	119.71	126.42	135.56	139.73	159.06
Retained Earnings	(405.04)	(389.24)	(366.11)	(343.32)	(329.23)	(246.99)	(219.61)	(186.16)	(127.97)	(99.11)	(59.69)	8.31	19.03	16.54	53.81	55.98	53.56
Total Stockholder Equity	429.18	435.19	442.49	458.35	458.29	525.92	546.00	570.32	615.48	639.99	664.16	333.54	341.95	335.58	364.83	362.28	354.82

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Total Revenue	210.93	196.71	219.91	205.63	203.12	193.65	215.66	196.61	198.62	188.61	200.42	184.01	187.02	175.20	122.23	114.00	118.07	106.42	125.06	112.43
Cost of Revenue	61.23	57.16	63.57	57.11	63.59	72.03	66.82	61.55	63.87	61.37	63.79	64.24	67.47	64.88	33.05	30.57	31.60	28.32	33.25	28.31
Gross Profit	149.71	139.55	156.34	148.52	139.53	121.62	148.84	135.05	134.75	127.24	136.63	119.76	119.55	110.33	89.18	83.42	86.47	78.10	91.81	84.12
Research & Development	15.94	15.32	15.37	14.77	15.93	19.77	18.81	17.29	18.05	19.49	18.94	18.56	19.42	23.31	13.15	11.94	12.76	11.21	13.24	12.36
Selling, General & Admin	138.03	134.91	136.75	148.10	136.49	132.98	136.48	33.56	33.99	31.65	34.53	27.14	34.18	48.81	25.47	19.32	15.85	19.33	18.26	16.31
Total Operating Expenses*	157.84	153.98	155.85	165.57	155.54	170.49	451.81	10.89	11.23	156.58	154.95	89.21	(9.04)	170.04	100.22	250.22	79.83	81.18	101.16	84.43
Operating Income	(8.13)	(14.44)	0.49	(17.05)	(16.00)	(48.87)	(11.48)	(18.90)	(24.91)	(29.34)	(18.32)	(24.45)	(36.63)	(59.71)	(11.04)	(5.79)	6.64	(3.08)	(9.35)	(0.31)
Pretax Income	(15.00)	(20.83)	(2.19)	(22.26)	(14.22)	(52.13)	(29.71)	(26.64)	(32.36)	(35.17)	(22.05)	(28.38)	(37.92)	(60.33)	(6.99)	(9.37)	3.04	(4.39)	(9.60)	(2.53)
Tax Provision	0.80	0.07	0.03	0.53	(0.14)	0.96	(0.56)	0.75	1.08	0.85	0.13	0.47	1.51	0.61	0.08	1.34	0.55	0.07	23.21	(0.36)
Net Income	(15.80)	(20.91)	(2.22)	(22.79)	(14.08)	(53.09)	(29.15)	(27.39)	(33.44)	(36.02)	(22.17)	(28.86)	(39.43)	(60.94)	(7.06)	(10.72)	2.49	(4.46)	(32.81)	(2.17)
Basic EPS	(0.39)	(0.52)	(0.05)	(0.57)	(0.36)	(1.35)	(0.76)	(0.71)	(0.88)	(0.95)	(0.57)	(0.77)	(1.07)	(1.71)	(0.35)	(0.53)	0.12	(0.22)	(1.66)	(0.11)
Diluted EPS	(0.39)	(0.52)	(0.05)	(0.57)	(0.36)	(1.35)	(0.76)	(0.71)	(0.88)	(0.95)	(0.57)	(0.77)	(1.07)	(1.71)	(0.35)	(0.53)	0.12	(0.22)	(1.66)	(0.11)

* Derived from reported values

Cash Flow Statement

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	(6.22)	(17.61)	27.70	12.40	11.64	(18.39)	23.73	11.67	8.98	(18.59)	(6.69)	0.48	(5.52)	(34.02)	2.35	(1.26)	(4.91)	(7.71)	11.78	6.43
Capital Expenditures	12.65	10.66	10.88	9.90	7.11	6.74	--	5.32	9.34	10.54	14.56	21.87	12.35	11.47	5.21	5.13	5.70	5.33	6.23	2.53
Free Cash Flow*	(18.87)	(28.27)	16.82	2.50	4.53	(25.13)	--	6.35	(0.36)	(29.14)	(21.25)	(21.39)	(17.87)	(45.49)	(2.86)	(6.39)	(10.62)	(13.04)	5.55	3.91
Investing Cash Flow	(12.65)	(10.51)	(10.87)	(9.89)	(7.10)	(6.74)	(1.13)	(5.86)	(9.72)	(10.87)	(15.05)	(22.34)	(12.82)	17.08	(5.90)	(5.47)	(7.49)	(5.67)	(8.98)	(4.24)
Financing Cash Flow	2.45	63.97	2.38	(5.15)	2.64	(0.65)	31.49	(2.46)	0.23	21.45	25.28	18.25	5.81	15.98	1.50	(0.25)	0.91	(2.23)	2.05	0.86

* Derived from reported values